2020. PREDICTIVE VALUE OF THE DYNAMIC DETERMINATION OF CIRCULATING TUMOR DNA ON PFS IN PATIENTS WITH EGFR MUTATED NSCLC, WITH OSIMERTINIB THERAPY. Voprosy onkologii. 66, 2 (Feb. 2020), 135–142. DOI:https://doi.org/10.37469/0507-3758-2020-66-2-135-142.